Full Press Release Details
Blog Post
| May 13, 2024
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
Read More
Previous Article
Next Article
Blog Navigation
VANI Neutral Sentiment
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
Key Takeaway: Vivani Medical has released a business update along with its financial results for the first quarter of 2024. The report includes key financial metrics and insights into the company's operations. However, specific details regarding performance or strategic initiatives were not disclosed in the article.
Price reaction · baseline $1.85 (2024-05-13 close) · hit after-hours · clean, no other VANI news in the window
day 0 close
-1.1%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceCash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight